About OcuSera
OcuSera is a medical device company developing centrifuge-free platelet-rich plasma preparation for clinicians who work with bone grafts.
What OcuSera does
OcuSera is developing the No Spin PRP® System, a portable, single-use device for preparing platelet-rich plasma (PRP) from a patient’s own blood.
A different approach to PRP preparation
No Spin PRP uses gravity-driven red-cell sedimentation to separate blood components without a centrifuge. Development studies will evaluate PRP composition, platelet function, and bone-graft handling.
Who we are developing it for
The proposed use is PRP preparation for clinicians working with autograft or allograft bone. The PRP would be mixed with bone before application to a bony defect, to improve handling characteristics.
Justin Karlin, MD, MS
Oculofacial plastic surgeon, teacher, and researcher
Dr. Karlin is an ABO board-certified ophthalmologist and ASOPRS-certified oculofacial plastic surgeon with more than 55 peer-reviewed publications. He founded OcuSera in 2023.
About Justin Karlin- Company
- OcuSera, Inc.Delaware corporation, incorporated June 2023
- Headquarters
- Los Angeles, California
- Field
- Medical device development
- Device
- No Spin PRP® SystemPolymer-accelerated, gravity-based blood separation for platelet-rich plasma preparation
- Stage
- In developmentCurrent planned research is ex vivo
- Regulatory status
- Investigational deviceNot cleared or approved by the U.S. FDA; not available for sale
- Founder and CEO
- Justin Karlin, MD, MS
- Proposed use
- Preparation of autologous platelet-rich plasma at the point of care for mixing with autograft and/or allograft bone before application to a bony defect, to improve handling characteristics.
- Website
- www.ocusera.com
Frequently asked questions
Are OcuSera and No Spin PRP the same?
OcuSera, Inc. is the company. The No Spin PRP® System is the device it is developing.
Is the No Spin PRP® System FDA cleared or approved?
No. It is an investigational device in development and has not been cleared or approved by the U.S. Food and Drug Administration.
Can I buy the No Spin PRP® System?
No. It is not available for sale, and OcuSera has no products on the market.
Does the system use a centrifuge or electricity?
No. Separation happens at normal gravity. A premixed proprietary polymer solution promotes red-cell aggregation, and the syringe rests tip-up at about 30° so the red cells settle while an upper plasma layer forms.
What is the proposed use?
Preparation of autologous platelet-rich plasma at the point of care for mixing with autograft and/or allograft bone before application to a bony defect, to improve handling characteristics.
Is the PRP given to people in current studies?
No. Current planned research is ex vivo: study PRP and graft are not administered to participants.
How can I discuss research or development opportunities?
Use the contact page to introduce your interest.
Research, clinical, and investor inquiries.
We welcome conversations with researchers, clinicians, and investors interested in centrifuge-free PRP preparation.
Contact OcuSera